Freshpet, Inc. (FRPT)
시가총액: 3.72B
국가: United States
산업: #Packaged_Foods
섹터: #Consumer_Staples
홈페이지: https://www.freshpet.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 263.2M / 265.01M / -0.7% / 17.6% / 0.2%
2412: 262.7M / 263.94M / -0.5% / 21.9% / 3.7%
2409: 253.4M / 248.21M / 2.1% / 26.3% / 7.7%
2406: 235.3M / 230.94M / 1.9% / 28.3% / 5.1%
2403: 223.85M / -- / -- / 33.6% / 3.9%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.26 / 0.15 / -273.3% / -170.3% / -172.2%
2412: 0.36 / 0.4 / -10.0% / 16.1% / 50.0%
2409: 0.24 / 0.15 / 60.0% / 260.0% / 900.0%
2406: -0.03 / -0.04 / 25.0% / 91.4% / -108.1%
2403: 0.37 / -- / -- / 171.2% / 19.4%

- 연간 매출(YoY%), EPS(YoY%)
2312: 766.89M(28.8%) / -0.7(45.7%)
2212: 595.34M(39.9%) / -1.29(-87.0%)
2112: 425.49M(33.5%) / -0.69(-762.5%)
2012: 318.79M(--) / -0.08(--)

#FRPT

- 사업요약: Freshpet, Inc., together with its subsidiaries, manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. It sells dog food,...

Park Hotels & Resorts Inc. (PK)
시가총액: 2.07B
국가: United States
산업: #Hotels_Resorts
섹터: #Consumer_Discretionary
홈페이지: https://www.pkhotelsandresorts.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 630M / 614.12M / 2.6% / -1.4% / 0.8%
2412: 625M / 610.3M / 2.4% / -4.9% / -3.7%
2409: 649M / 648.04M / 0.1% / -4.4% / -5.4%
2406: 686M / 691.83M / -0.8% / -3.9% / 7.4%
2403: 639.0M / -- / -- / -1.4% / -2.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.29 / 0.08 / -462.5% / -323.1% / -190.6%
2412: 0.32 / 0.07 / 357.1% / -63.6% / 23.1%
2409: 0.26 / 0.14 / 85.7% / 100.0% / -13.3%
2406: 0.3 / 0.28 / 7.1% / 142.9% / 130.8%
2403: 0.13 / -- / -- / -13.3% / -85.2%

- 연간 매출(YoY%), EPS(YoY%)
2312: 2.7B(7.9%) / 0.44(-38.0%)
2212: 2.5B(83.6%) / 0.71(136.4%)
2112: 1.36B(59.9%) / -1.95(68.1%)
2012: 852.0M(--) / -6.11(--)

#PK

- 사업요약: Park is one of the largest publicly-traded lodging real estate investment trusts (“REIT”) with a diverse portfolio of iconic and market-leading hotels and resorts with significant underlying re...

TG Therapeutics, Inc. (TGTX)
시가총액: 6.9B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.tgtherapeutics.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 119.7M / 117.13M / 2.2% / 88.6% / 10.6%
2412: 108.19M / 97.66M / 10.8% / 146.0% / 29.9%
2409: 83.3M / 81.21M / 2.6% / -49.8% / 13.4%
2406: 73.47M / 65.89M / 11.5% / 357.1% / 15.7%
2403: 63.47M / -- / -- / 713.5% / 44.4%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.03 / 0.16 / -81.2% / 142.9% / -80.0%
2412: 0.15 / 0.08 / 87.5% / 250.0% / 650.0%
2409: 0.02 / 0.02 / 0.0% / -97.3% / -50.0%
2406: 0.04 / -0.05 / 180.0% / 111.8% / 157.1%
2403: -0.07 / -- / -- / 75.0% / 30.0%

- 연간 매출(YoY%), EPS(YoY%)
2312: 233.66M(8290.0%) / 0.09(106.2%)
2212: 2.79M(-58.4%) / -1.46(44.5%)
2112: 6.69M(4300.7%) / -2.63(-8.7%)
2012: 152000.0(--) / -2.42(--)

#TGTX

- 사업요약: TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-ce...

Napco Security Technologies, Inc. (NSSC)
시가총액: 865.63M
국가: United States
산업: #Telecommunications_Equipment
섹터: #Telecommunications
홈페이지: https://www.napcosecurity.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 43.96M / 45.83M / -4.1% / -10.8% / 2.4%
2412: 42.93M / 49.92M / -14.0% / -9.7% / -2.4%
2409: 44M / 47.3M / -7.0% / 5.6% / -12.6%
2406: 50.33M / 50.13M / 0.4% / 12.7% / 2.2%
2403: 49.27M / -- / -- / 13.2% / 3.6%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.36 / 0.29 / 24.1% / 0.0% / 28.6%
2412: 0.28 / 0.34 / -17.6% / -17.6% / -6.7%
2409: 0.3 / 0.34 / -11.8% / 7.1% / -16.7%
2406: 0.36 / 0.355 / 1.4% / -- / 0.0%
2403: 0.36 / -- / -- / 24.1% / 5.9%

- 연간 매출(YoY%), EPS(YoY%)
2306: 170.0M(18.4%) / 0.73(37.7%)
2206: 143.59M(25.9%) / 0.53(30.9%)
2106: 114.03M(12.5%) / 0.405(76.1%)
2006: 101.36M(--) / 0.23(--)

#NSSC

- 사업요약: Napco Security Technologies, Inc. develops, manufactures, and sells electronic security systems for commercial, residential, institutional, industrial, and governmental applications ...

BioNTech SE (BNTX)
시가총액: 25.18B
국가: Germany
산업: #Biotechnology_Biological_Products_No_Diagnostic_Substances
섹터: #Health_Care
홈페이지: https://www.biontech.de

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 182.8M / 204.08M / -10.4% / -2.6% / -84.6%
2412: 1.19B / 1.12B / 6.2% / -19.5% / -4.0%
2409: 1.24B / 565.56M / 119.3% / 38.5% / 863.5%
2406: 128.7M / 134.98M / -4.7% / -23.3% / -31.4%
2403: 187.6M / -- / -- / -85.3% / -87.3%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -1.73 / -2.0 / 13.5% / -32.1% / -260.2%
2412: 1.08 / 0.4767 / 126.6% / -- / 33.3%
2409: 0.81 / -1.55 / 152.3% / 20.9% / 124.1%
2406: -3.36 / -2.02 / -66.3% / -325.3% / -156.5%
2403: -1.31 / -- / -- / -163.9% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 3.82B(-77.9%) / 3.83(-89.9%)
2212: 17.31B(-8.8%) / 37.77(-4.7%)
2112: 18.98B(3834.6%) / 39.63(65950.0%)
2012: 482.3M(--) / 0.06(--)

#BNTX

- 사업요약: BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac p...

Ocular Therapeutix, Inc. (OCUL)
시가총액: 1.4B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.ocutx.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 10.7M / 17.07M / -37.3% / -27.6% / -37.4%
2412: 17.08M / 17.21M / -0.8% / 15.4% / 10.8%
2409: 15.42M / 17.13M / -10.0% / 2.2% / -6.2%
2406: 16.44M / 15.85M / 3.7% / 8.3% / 11.3%
2403: 14.77M / -- / -- / 10.5% / -0.2%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.38 / -0.29 / -31.0% / 22.4% / -31.0%
2412: -0.29 / -0.25 / -16.0% / -- / -31.8%
2409: -0.22 / -0.24 / 8.3% / 12.0% / 15.4%
2406: -0.26 / -0.22 / -18.2% / 0.0% / 46.9%
2403: -0.49 / -- / -- / -25.6% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 58.44M(13.5%) / --(--)
2212: 51.49M(18.3%) / -0.97(1.0%)
2112: 43.52M(150.1%) / -0.98(61.7%)
2012: 17.4M(--) / -2.56(-34.0%)

#OCUL

- 사업요약: Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bi...

IRADIMED CORPORATION (IRMD)
시가총액: 679.87M
국가: United States
산업: #Medical_Dental_Instruments
섹터: #Health_Care
홈페이지: https://www.iradimed.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 19.5M / 19.13M / 1.9% / 10.8% / 0.6%
2412: 19.39M / 18.8M / 3.1% / 11.1% / 5.8%
2409: 18.33M / 18.1M / 1.3% / 11.1% / 2.2%
2406: 17.93M / 17.65M / 1.6% / 11.2% / 1.9%
2403: 17.6M / -- / -- / 13.7% / 0.8%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.42 / 0.41 / 2.4% / 31.2% / -4.5%
2412: 0.44 / 0.405 / 8.6% / 22.2% / 2.3%
2409: 0.43 / 0.39 / 10.3% / 7.5% / 2.4%
2406: 0.42 / 0.37 / 13.5% / 27.3% / 31.2%
2403: 0.32 / -- / -- / 18.5% / -11.1%

- 연간 매출(YoY%), EPS(YoY%)
2312: 65.56M(23.0%) / 1.35(32.4%)
2212: 53.3M(27.5%) / 1.02(37.8%)
2112: 41.81M(31.8%) / 0.74(572.7%)
2012: 31.72M(--) / 0.11(--)

#IRMD

- 사업요약: IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internatio...

Cummins Inc. (CMI)
시가총액: 41.3B
국가: United States
산업: #Industrial_Machinery_Components
섹터: #Industrials
홈페이지: https://www.cummins.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 8.17B / 8.24B / -0.8% / -2.8% / -3.3%
2412: 8.45B / 8.08B / 4.6% / -1.1% / -0.6%
2409: 8.5B / 8.29B / 2.5% / 0.8% / -3.4%
2406: 8.8B / 8.33B / 5.6% / 1.9% / 4.7%
2403: 8.4B / -- / -- / -0.6% / -1.6%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 5.96 / 5.02 / 18.7% / -57.5% / 97.4%
2412: 3.02 / 4.71 / -35.9% / 130.0% / -48.5%
2409: 5.86 / 4.82 / 21.6% / 27.7% / 11.4%
2406: 5.26 / 4.83 / 8.9% / 4.2% / -62.5%
2403: 14.03 / -- / -- / 152.8% / 239.2%

- 연간 매출(YoY%), EPS(YoY%)
2312: 34.06B(21.3%) / 5.15(-65.9%)
2212: 28.07B(16.9%) / 15.12(3.5%)
2112: 24.02B(21.3%) / 14.61(21.6%)
2012: 19.81B(--) / 12.01(--)

#CMI

- 사업요약: Cummins Inc. designs, manufactures, distributes, and services diesel and natural gas engines, electric and hybrid powertrains, and related components worldwide. It operates through five segments: Engine, Distribution, Co...

Tyson Foods, Inc. (TSN)
시가총액: 21.65B
국가: United States
산업: #Meat_Poultry_Fish
섹터: #Consumer_Staples
홈페이지: https://www.tysonfoods.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 13.07B / 13.16B / -0.7% / -0.0% / -4.0%
2412: 13.62B / 13.5B / 0.9% / 2.3% / 0.4%
2409: 13.57B / 13.43B / 1.0% / 1.7% / 1.6%
2406: 13.35B / 13.21B / 1.1% / 1.6% / 2.1%
2403: 13.07B / -- / -- / -0.5% / -1.9%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.92 / 0.84 / 9.5% / 124.4% / -19.3%
2412: 1.14 / 0.9 / 26.7% / 280.0% / 23.9%
2409: 0.92 / 0.71 / 29.6% / -- / 5.7%
2406: 0.87 / 0.67 / 29.9% / 173.7% / 112.2%
2403: 0.41 / -- / -- / 246.4% / 36.7%

- 연간 매출(YoY%), EPS(YoY%)
2309: 52.88B(-0.8%) / -1.87(-121.0%)
2209: 53.28B(13.2%) / 8.92(7.0%)
2109: 47.05B(8.9%) / 8.34(47.9%)
2009: 43.19B(--) / 5.64(--)

#TSN

- 사업요약: Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company processes live fed cattle and hogs; fabrica...

Axsome Therapeutics, Inc. (AXSM)
시가총액: 5.52B
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://www.axsome.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 121.46M / 121.58M / -0.1% / 61.9% / 3.5%
2412: 117.32M / 117.69M / -0.3% / 64.0% / 13.1%
2409: 103.74M / 98.32M / 5.5% / 79.5% / 19.0%
2406: 87.2M / 86.66M / 0.6% / 86.7% / 16.3%
2403: 75.0M / -- / -- / -20.7% / 4.8%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -1.22 / -1.3 / 6.2% / 15.3% / 20.8%
2412: -1.54 / -0.96 / -60.4% / 26.0% / -14.9%
2409: -1.34 / -1.38 / 2.9% / -1.5% / 19.8%
2406: -1.67 / -1.31 / -27.5% / -8.4% / -16.0%
2403: -1.44 / -- / -- / -453.8% / 30.8%

- 연간 매출(YoY%), EPS(YoY%)
2312: 270.6M(440.8%) / -5.27(-14.6%)
2212: 50.04M(--) / -4.6(-32.6%)
2112: 0.0(--) / -3.47(-25.3%)
2012: 0.0(--) / -2.77(--)

#AXSM

- 사업요약: Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's...